Clinical Trial Update: Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of RHUMAB VEGF with capecitabine-based chemoradiation for locally advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• RHUMAB VEGF

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED